Kava Kava for the Treatment of Generalized Anxiety Disorder (GAD)

This study has been terminated.

(European reports of liver toxicity from kava meant that the study had to stop)

Sponsor:

Information provided by (Responsible Party):

National Center for Complementary and Alternative Medicine (NCCAM)

ClinicalTrials.gov Identifier:

NCT00083980

First received: June 4, 2004

Last updated: October 18, 2012

Last verified: August 2006

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been terminated.
Study Completion Date:	August 2004
Primary Completion Date:	June 2004 (Final data collection date for primary outcome measure)